Nabi Biopharmaceuticals Announces Third Quarter 2008 Financial Results
November 06, 2008 16:05 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Nov. 6, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its third quarter financial results for the three month period ended September 27, 2008. The...
Nabi Biopharmaceuticals Announces Successful Final Results of NicVAX(r) Immunogenicity Study
October 29, 2008 09:25 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 29, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today positive final results from its Phase 2 NicVAX(r) (Nicotine Conjugate Vaccine) schedule...
Nabi Biopharmaceuticals to Announce Third Quarter Financial Results On November 6, 2008
October 27, 2008 15:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 27, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its third quarter 2008 financial results on Thursday, November 6, 2008,...
Nabi Biopharmaceuticals and NIAID to Advance PentaStaph Vaccine Research
September 09, 2008 08:30 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Sept. 9, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that the National Institute of Allergy and Infectious Diseases (NIAID), one of the National...
Nabi Biopharmaceuticals Announces Second Quarter 2008 Financial Results
August 07, 2008 16:05 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Aug. 7, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its second quarter financial results for the three month period ended June 28, 2008. The Company...
Nabi Biopharmaceuticals Announces Arbitration Settlement With Inhibitex, Inc.
August 04, 2008 16:30 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Aug. 4, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today a settlement of an arbitration proceeding against Inhibitex, Inc., effective August 1, 2008....
Nabi Biopharmaceuticals to Announce Second Quarter Financial Results On August 7, 2008
July 29, 2008 09:30 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., July 29, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its second quarter 2008 financial results on Thursday, August 7, 2008, after...
Nabi Biopharmaceuticals Announces Positive Interim Results of NicVAX Immunogenicity Study
July 23, 2008 09:15 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., July 23, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today positive interim results from its Phase 2 NicVAX(r) (Nicotine Conjugate Vaccine) schedule...
Nabi Biopharmaceuticals Announces Receipt of $2.5 Million Milestone Payment
June 03, 2008 09:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., June 3, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) has received a $2.5 million payment from Fresenius USA Manufacturing, Inc. (Fresenius) for the successful...
Nabi Biopharmaceuticals Announces First Quarter 2008 Financial Results
May 08, 2008 16:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., May 8, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its first quarter financial results for the three month period ended March 29, 2008. The Company...